Carlo Della Rocca
Overview
Explore the profile of Carlo Della Rocca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
956
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maiuro A, Di Stadio F, Palombo M, Ciardiello A, Satta S, Pernazza A, et al.
Med Phys
. 2025 Feb;
PMID: 40018821
Background: Endometrial cancer (EC) is one of the most common gynecological malignancies and the second most common gynecological malignancy cause of death in women. Heterogeneous tissues with different grades of...
2.
Chiappetta C, Della Rocca C, Di Cristofano C
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769419
Osteosarcoma (OS) is the most prevalent malignant bone tumor in adolescents and young adults. OS cells grow in a permissive local microenvironment which modulates their behavior and facilitates all steps...
3.
Di Donato V, Caruso G, Golia DAuge T, Perniola G, Palaia I, Tomao F, et al.
Arch Gynecol Obstet
. 2024 Oct;
311(2):429-436.
PMID: 39397086
Purpose: To determine the prognostic impact of microscopic residual disease after neoadjuvant chemotherapy (NACT) in patients undergoing interval debulking surgery (IDS) for advanced epithelial ovarian cancer (AEOC). Methods: Patients affected...
4.
Botticelli A, Cirillo A, dAmati G, Di Gioia C, Corsi A, Della Rocca C, et al.
Pathol Res Pract
. 2024 Jul;
260:155415.
PMID: 38996615
Immunotherapy has a crucial role in the treatment of recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, only a small percentage of patients achieve long-term benefit in terms...
5.
Candela V, Peruzzi B, Leopizzi M, Porta N, Di Maio V, Greenberg B, et al.
J Orthop Traumatol
. 2024 Feb;
25(1):8.
PMID: 38381214
Background: The network of intermediate filament proteins underlying the inner nuclear membrane forms the nuclear lamina. Lamins have been associated with important cellular functions: DNA replication, chromatin organization, differentiation of...
6.
Cerbelli B, Cirillo A, Pomati G, Pernazza A, Ascione A, Pisegna S, et al.
Tumori
. 2023 Sep;
110(1):44-48.
PMID: 37726962
Background: Immunotherapy has revolutionized the approach to metastatic triple-negative breast cancers. Atezolizumab was approved for patients with metastatic triple-negative breast cancers whose tumors express PD-L1, determined by SP 142 assay....
7.
Mottola E, Adotti F, Pernazza A, Della Rocca C, dAmati G, Nardis P, et al.
J Cardiothorac Surg
. 2023 Jul;
18(1):205.
PMID: 37400894
Background: Xanthomas are well-circumscribed benign proliferative lesions seen mainly in soft tissues. Usually, they are found in hyperlipidemia and familial hyperlipoproteinemia. Histologically, are characterized by macrophage-like mononuclear cells, multinucleated giant...
8.
Tenore G, Mohsen A, Rocchetti F, Rossi G, Cassoni A, Battisti A, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296965
This study aims to retrospectively assess the potential risk of malignant transformation in patients with diagnosed oral lichen planus (OLP) between 2015 and 2022, and to evaluate the influence of...
9.
Merlino L, DOvidio G, Matys V, Piccioni M, Porpora M, Senatori R, et al.
Pharmaceuticals (Basel)
. 2023 Apr;
16(4).
PMID: 37111307
(1) Background: Genitourinary syndrome of menopause (GSM) is a medical condition that can affect breast cancer survivors (BCS). This is a complication that often can occur as a result of...
10.
Di Donato V, Kontopantelis E, Cuccu I, Sgamba L, Golia DAuge T, Pernazza A, et al.
Int J Gynecol Cancer
. 2023 Apr;
33(7):1070-1076.
PMID: 37094971
Objective: Endometrial carcinoma is the most common gynecological tumor in developed countries. Clinicopathological factors and molecular subtypes are used to stratify the risk of recurrence and to tailor adjuvant treatment....